PURLs: a safer way to prevent VTE recurrence

Area of Science:

• Cardiology
• Hematology
• Internal Medicine

Background:

• Venous thromboembolism (VTE) poses a significant risk for recurrent events.
• Extended oral anticoagulation therapy (OAT) is a common strategy for VTE secondary prevention.
• Long-term OAT carries risks, including bleeding and patient adherence challenges.

Purpose of the Study:

• To evaluate the efficacy and safety of daily aspirin compared to extended OAT for preventing recurrent VTE in high-risk patients.
• To determine if aspirin provides a viable alternative to prolonged anticoagulation for VTE secondary prevention.

Main Methods:

• A comparative study design was employed.
• Patients at high risk for VTE recurrence were identified.
• Treatment arms included daily aspirin versus extended OAT.

Main Results:

• Daily aspirin demonstrated comparable efficacy to extended OAT in preventing VTE recurrence.
• The aspirin group showed a lower incidence of major bleeding events.
• Patient-reported outcomes favored the aspirin regimen due to its simplicity.

Conclusions:

• Daily aspirin is a safe and effective alternative to extended OAT for selected high-risk patients with VTE.
• Aspirin therapy simplifies long-term VTE management and reduces bleeding risk.
• Clinical guidelines should consider aspirin as a primary option for VTE secondary prevention in appropriate patient populations.